Naila Rabbani
- Clinical Biochemistry top 0.02%
- Molecular Biology top 5%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Physiology top 1%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Paul J. ThornalleyMingzhan XueRoya Babaei‐JadidiAntonysunil AdaikalakoteswariAttia AnwarJames R. LarkinMartin O. WeickertAmal Adnan Ashour
- Topics
- Advanced Glycation End Products research (79 papers)Biochemical effects in animals (22 papers)Genomics, phytochemicals, and oxidative stress (12 papers)
- Journals
- Nucleic Acids ResearchJournal of Biological ChemistrySHILAP Revista de lepidopterología
- Partner nations
- United KingdomQatarGermany
In The Last Decade
Naila Rabbani
128 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Clinical Biochemistry 3.8k
- Molecular Biology 2.4k
- Endocrinology, Diabetes and Metabolism 1.8k
- Physiology 1.6k
- Pathology and Forensic Medicine 869
Countries citing papers authored by Naila Rabbani
This map shows the geographic impact of Naila Rabbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naila Rabbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naila Rabbani more than expected).
Fields of papers citing papers by Naila Rabbani
This network shows the impact of papers produced by Naila Rabbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naila Rabbani. The network helps show where Naila Rabbani may publish in the future.
Co-authorship network of co-authors of Naila Rabbani
This figure shows the co-authorship network connecting the top 25 collaborators of Naila Rabbani. A scholar is included among the top collaborators of Naila Rabbani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naila Rabbani. Naila Rabbani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 12 | |
| 4 | 26 | |
| 5 | 34 | |
| 6 | 16 | |
| 7 | 5 | |
| 8 | 48 | |
| 9 | 21 | |
| 10 | 9 | |
| 11 | 3 | |
| 12 | 18 | |
| 13 | 75 | |
| 14 | 19 | |
| 15 | 35 | |
| 16 | 72 | |
| 17 | 291 | |
| 18 | 60 | |
| 19 | Prevention of decline in glycaemic control in streptozotocin-induced diabetic rats by thiamine but not by Benfotiamine | 2 |
| 20 | 137 |
About Naila Rabbani
Naila Rabbani is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 130 papers that have together received 7.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (79 papers), Biochemical effects in animals (22 papers) and Genomics, phytochemicals, and oxidative stress (12 papers). The work is most often cited by research in Clinical Biochemistry (3.8k citations), Endocrinology, Diabetes and Metabolism (1.8k citations) and Biochemistry (487 citations). Naila Rabbani has collaborated with scholars based in United Kingdom, Qatar and Germany. Frequent co-authors include Paul J. Thornalley, Mingzhan Xue, Roya Babaei‐Jadidi, Antonysunil Adaikalakoteswari, Attia Anwar, James R. Larkin, Martin O. Weickert, Amal Adnan Ashour, Usman Ahmed and Lisa Godfrey. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.